Table III.
Common data set | Completeness (% missing)a | Accuracy | ||
---|---|---|---|---|
| ||||
Whole database | Calendar years 2010–2011 | Calendar year 2012 (6 months) | ||
(110,841 records) | (27,114 records) | (9,913 records) | ||
Gender | 0.0 | 0.0 | 0.0 | Data is collected consistently among data sources according to usual identification procedures |
Date of birth | 0.0 | 0.0 | 0.0 | Data is collected consistently among data sources according to usual identification procedures |
Region of residence | 0.1 | 0.1 | 0.0 | Data is collected consistently among data sources according to usual identification procedures |
Diagnosis | 0.0 | 0.0 | 0.0 | Diagnoses are controlled and validated by the RRsb and their accuracy rely on the selection criteria for the centres to become FDC of the RD network |
Date of diagnosis | 1.0 | -- | -- | Inconsistencies among regions on the identification of the relevant diagnostic event and diagnostic centre. |
Centre of RD diagnosis | 11.9 | 1.2 | 0.4 | Inconsistencies among regions on the identification of the relevant diagnostic event and diagnostic centre. A centre may change name following reorganisation. |
Vital status | ND | ND | ND c | Uncertainties in this variable depend on the fact that the data sources of RRsb may not be fully aware of the reason why patients are lost to follow up. In the future, date of decease will be collected from death registries: this will result in a systematic and precise, although delayed, appraisal of this condition. |
Date of decease | ND | ND | ND | Expectedly good (when reported). In the future, date of decease will be collected from death registries: this will result in a systematic and precise, although delayed, appraisal of this condition. |
Date of disease onset | 46.4 | 57.1 | 81.4 | Uncertainties in this variable depend on i) lack of patient’s recollection; ii) gradual appearance of unspecific symptoms over a long period. Symptoms could also not set on due to effective treatment following early diagnosis (e.g. following neonatal screening) |
Orphan drug used | 14.9 | 10.7 | 4.6 | The name of the active substance is communicated, but no standard catalogue or coding is used. |
Data completeness is measured as the proportion (%) of records without the indication of the value of the variable; calendar years refer to the date of diagnosis;
Regional registry;
ND = not determined